1. Home
  2. REGN vs NKE Comparison

REGN vs NKE Comparison

Compare REGN & NKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REGN
  • NKE
  • Stock Information
  • Founded
  • REGN 1988
  • NKE 1964
  • Country
  • REGN United States
  • NKE United States
  • Employees
  • REGN N/A
  • NKE N/A
  • Industry
  • REGN Biotechnology: Pharmaceutical Preparations
  • NKE Shoe Manufacturing
  • Sector
  • REGN Health Care
  • NKE Consumer Discretionary
  • Exchange
  • REGN Nasdaq
  • NKE Nasdaq
  • Market Cap
  • REGN 110.0B
  • NKE 117.4B
  • IPO Year
  • REGN 1991
  • NKE 1980
  • Fundamental
  • Price
  • REGN $701.85
  • NKE $76.96
  • Analyst Decision
  • REGN Buy
  • NKE Buy
  • Analyst Count
  • REGN 24
  • NKE 33
  • Target Price
  • REGN $1,054.00
  • NKE $93.45
  • AVG Volume (30 Days)
  • REGN 920.8K
  • NKE 14.0M
  • Earning Date
  • REGN 01-31-2025
  • NKE 12-19-2024
  • Dividend Yield
  • REGN N/A
  • NKE 2.08%
  • EPS Growth
  • REGN 15.31
  • NKE N/A
  • EPS
  • REGN 40.43
  • NKE 3.24
  • Revenue
  • REGN $13,847,100,000.00
  • NKE $48,978,000,000.00
  • Revenue This Year
  • REGN $10.20
  • NKE N/A
  • Revenue Next Year
  • REGN $4.16
  • NKE $4.30
  • P/E Ratio
  • REGN $17.36
  • NKE $23.74
  • Revenue Growth
  • REGN 5.72
  • NKE N/A
  • 52 Week Low
  • REGN $693.00
  • NKE $70.75
  • 52 Week High
  • REGN $1,211.20
  • NKE $110.80
  • Technical
  • Relative Strength Index (RSI)
  • REGN 27.80
  • NKE 46.36
  • Support Level
  • REGN $693.00
  • NKE $76.66
  • Resistance Level
  • REGN $745.00
  • NKE $79.00
  • Average True Range (ATR)
  • REGN 21.29
  • NKE 1.83
  • MACD
  • REGN 0.05
  • NKE -0.06
  • Stochastic Oscillator
  • REGN 8.20
  • NKE 33.24

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in immunology; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and CRISPR-based gene editing (Intellia).

About NKE Nike Inc.

Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.

Share on Social Networks: